| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activation of the Serine/Threonine Protein Kinase AKT During the Progression of Colorectal Neoplasia
|
Saglam, Ozlen
|
|
2007
|
6 |
9 |
p. 652-656
5 p.
|
artikel
|
| 2 |
Clinical Colorectal Cancer: “Ode to 5-Fluorouracil”
|
Chu, Edward
|
|
2007
|
6 |
9 |
p. 609-
1 p.
|
artikel
|
| 3 |
Combined-Modality Therapy for Rectal Cancer: Future Prospects
|
Czito, Brian G.
|
|
2007
|
6 |
9 |
p. 625-633
9 p.
|
artikel
|
| 4 |
Highlights from: The 43rd Annual Meeting of the American Society of Clinical Oncology; Chicago, IL; June 1–5, 2007
|
Grothey, Erin
|
|
2007
|
6 |
9 |
p. 614-620
7 p.
|
artikel
|
| 5 |
Metachronous Metastasis to the Penis from a Rectal Adenocarcinoma
|
Ketata, Sabeur
|
|
2007
|
6 |
9 |
p. 657-659
3 p.
|
artikel
|
| 6 |
Oxaliplatin and Fixed-Rate Infusional Gemcitabine in the Second-Line Treatment of Patients with Metastatic Colon Cancer: Final Results of a Phase II Trial Prematurely Closed as a Result of Poor Accrual
|
Lopes, Gilberto
|
|
2007
|
6 |
9 |
p. 641-645
5 p.
|
artikel
|
| 7 |
Phase II Trial of 5-Fluorouracil/Leucovorin/Gemcitabine/Cisplatin as Second-Line Treatment in Patients with Metastatic or Recurrent Colorectal Carcinoma: A Cancer Therapeutics Research Group Study
|
Chang, Alex Y.
|
|
2007
|
6 |
9 |
p. 646-651
6 p.
|
artikel
|
| 8 |
Selected Clinical Trials in Colorectal Cancer
|
|
|
2007
|
6 |
9 |
p. 660-661
2 p.
|
artikel
|
| 9 |
The Clinical Efficacy of FOLFIRI and Bevacizumab in Combination as First-Line Therapy of Metastatic Colorectal Cancer
|
Grothey, Erin
|
|
2007
|
6 |
9 |
p. 621-624
4 p.
|
artikel
|
| 10 |
Two Doses of Oxaliplatin with Capecitabine (XELOX) in Metastatic Colorectal Cancer
|
Moreno-Solórzano, Isabel
|
|
2007
|
6 |
9 |
p. 634-640
7 p.
|
artikel
|
Tijdschrift beschrijving